Skip to main content

Symposium 2014: Targeting KRAS Directly and Indirectly

Symposium 2014: Targeting KRAS Directly and Indirectly

Dr. Stephen W. Fesik, Vanderbilt-Ingram Cancer Center, describes how fragment-based methods can be applied to trying to drug the undruggable.